SCHEMBL2535974

SCHEMBL2535974

CN1CCN(CCOc2n[nH]c3cncc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c23)CC1

nearest known ligand 0.71

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EGFR P00533 18/20 0.71
ERBB2 P04626 16/20 0.71
KCNH2 Q12809 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2542968 0.95 EGFR (0.71) EGFRERBB2KCNH2
SCHEMBL5518435 0.93 EGFR (0.71) EGFRERBB2KCNH2
SCHEMBL5517462 0.91 ERBB2 (0.72) EGFRERBB2KCNH2
SCHEMBL5520007 0.91 EGFR (0.65) EGFRERBB2KCNH2
SCHEMBL2544297 0.90 EGFR (0.58) EGFRERBB2KCNH2
SCHEMBL2539611 0.89 ERBB2 (0.67) EGFRERBB2KCNH2
SCHEMBL2523859 0.88 EGFR (0.68) EGFRERBB2
SCHEMBL2520799 0.87 ERBB2 (0.57) EGFRERBB2KCNH2
SCHEMBL2520501 0.87 ERBB2 (0.57) EGFRERBB2
SCHEMBL2537843 0.87 EGFR (0.60) EGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838712-B8 PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2011-10-12 EP disclosed
EP-1838712-A1 PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS AstraZeneca AB (SE) 2007-10-03 EP disclosed
WO-2006064196-A1 PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2006-06-22 WO disclosed